01 6GlaxoSmithKline Inc.
01 32702650
02 32951883
01 6MOMELOTINIB DIHYDROCHLORIDE
01 6TABLET
01 31935-06-11
02 32028-03-12
Patent Expiration Date : 2028-03-12
Date Granted : 2017-01-03
Brand Name : OJJAARA
Patent Number : 2702650
Filing Date : 2008-03-12
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-12
Date Granted : 2017-01-03
Patent Expiration Date : 2028-03-12
Date Granted : 2017-01-03
Brand Name : OJJAARA
Patent Number : 2702650
Filing Date : 2008-03-12
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-12
Date Granted : 2017-01-03
Patent Expiration Date : 2028-03-12
Date Granted : 2017-01-03
Brand Name : OJJAARA
Patent Number : 2702650
Filing Date : 2008-03-12
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-03-12
Date Granted : 2017-01-03
Patent Expiration Date : 1935-06-11
Date Granted : 2020-05-05
Brand Name : OJJAARA
Patent Number : 2951883
Filing Date : 2015-06-11
Strength per Unit : 100 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-06-11
Date Granted : 2020-05-05
Patent Expiration Date : 1935-06-11
Date Granted : 2020-05-05
Brand Name : OJJAARA
Patent Number : 2951883
Filing Date : 2015-06-11
Strength per Unit : 150 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-06-11
Date Granted : 2020-05-05
Patent Expiration Date : 1935-06-11
Date Granted : 2020-05-05
Brand Name : OJJAARA
Patent Number : 2951883
Filing Date : 2015-06-11
Strength per Unit : 200 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 1935-06-11
Date Granted : 2020-05-05
